Wells Fargo & Company »

Tourmaline Bio shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.9k 126 22.90
2023-12-31 $2.2k 83 26.18